PITTENGER & ANDERSON INC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
PITTENGER & ANDERSON INC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$10,000
+66.7%
3,0000.0%0.00%
Q3 2019$6,000
-33.3%
3,0000.0%0.00%
-100.0%
Q2 2019$9,000
-18.2%
3,0000.0%0.00%0.0%
Q1 2019$11,000
-8.3%
3,0000.0%0.00%0.0%
Q4 2018$12,000
-29.4%
3,0000.0%0.00%0.0%
Q3 2018$17,000
+41.7%
3,0000.0%0.00%0.0%
Q2 2018$12,000
-14.3%
3,0000.0%0.00%0.0%
Q1 2018$14,000
+16.7%
3,0000.0%0.00%0.0%
Q4 2017$12,000
-36.8%
3,0000.0%0.00%
-50.0%
Q3 2017$19,000
-20.8%
3,0000.0%0.00%0.0%
Q2 2017$24,000
+14.3%
3,0000.0%0.00%0.0%
Q4 2016$21,0003,0000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders